Ourobio’s pitch deck is a concise, 9-slide technical overview of a company aiming to replace petrochemistry with biotechnology. The company focuses on a proprietary bioprocess that converts organic industrial byproducts, specifically dairy waste, into low-footprint biodegradable plastic colorant masterbatches. The deck highlights significant early-stage traction, including reaching TRL 3/4 and filing a provisional patent in March 2022. While the team slide showcases strong academic backgrounds and a wide array of accelerator logos, the deck is notably missing critical investment data. There i…
Key takeaways
- The company utilizes a single fermentation step to produce complementary bio-based additives simultaneously (Slide 4).
- Ourobio has reached Technology Readiness Level (TRL) 3/4, producing polymers and colorants from whey (Slide 5).
- A provisional patent was filed on March 3, 2022, to protect their proprietary engineered strains (Slide 5).
- The startup claims over 1,000 hours of market discovery resulting in MOUs from upstream and downstream partners (Slide 5).
- The product roadmap extends from blue masterbatches to a portfolio of PHA co-polymers and multi-colored masterbatches (Slide 6).
- The team consists of two co-founders with backgrounds in Biomedical Engineering and Chemistry, supported by numerous accelerator programs like Plug and Play and MassChallenge (Slide 7).
- The deck lacks all financial metrics, including revenue models, burn rate, and a specific funding target (Slide 8).
- There is no analysis of the competitive landscape or specific market size figures provided in the 9 slides.
Ourobio Pitch Deck Analysis
Ourobio presents a highly technical, early-stage pitch deck focused on the circular bioeconomy. The deck is visually clean but leans heavily on the 'what' and 'how' of the technology while providing very little information on the 'how much' or 'who else.' As a 9-slide deck, it serves as a primer for the company's mission to turn industrial waste into high-value chemical additives.
Slide 1: Title Slide
The deck opens with the Ourobio logo and the tagline: "Catalyzing the circular bioeconomy." The branding uses soft blues and greens, reinforcing the environmental and biological nature of the business. There are no specific contact details or dates on this slide, keeping the focus entirely on the brand identity.
Slide 2: The Vision
Slide 2 is a simple statement slide: "Biotechnology is the sustainable alternative to petrochemistry." This serves as the high-level problem/solution hook. It identifies the incumbent industry (petrochemistry) and the proposed replacement (biotechnology). While effective as a transition, it lacks a specific 'pain point' description regarding current petrochemical costs or environmental regulations.
Slide 3: The Tech Overview
Titled "Tech," this slide defines Ourobio's role as a "bioeconomy partner" for the chemical and materials industry. It uses a three-part flow diagram: Organic waste from industry flows into Ourobio's proprietary bioprocesses , which result in Low-footprint, bio-based chemicals & materials . The text emphasizes that these additives are "targeted" and help create "circular and regenerative" supply chains.
Slide 4: Our First Product
This slide provides the most specific technical detail in the deck. It explains that their proof of concept involves turning dairy waste into biodegradable plastic colorant masterbatches . A chemical diagram shows the conversion of carbohydrates and amino acids into PHB (polyhydroxybutyrate) and biosynthetic pigments. The key value proposition here is a "single fermentation step" to produce two complementary additives simultaneously, which implies significant process efficiency.
Slide 5: Traction and Achievements
Slide 5 covers the first two years of activity. Key metrics include:
TRL 3/4: Reached through bootstrapped R&D. · 1000+ hours: Spent on market discovery. · MOUs: Secured from upstream and downstream partners. · Patent: Provisional patent filed March 3, 2022.
The slide also features a badge from StartUs Insights naming them a top 5 biomaterials startup for 2022.
Slide 6: Roadmap
The roadmap outlines an "elaborate vision to build out pipeline." It starts with the current Blue Biosynthetic Masterbatches and moves toward:
Biodegradable Plastic Blends. · Portfolio of PHA co-polymers. · Multi-colored Masterbatches. · Novel, performance-enhancing additives.
This slide illustrates that the company views its current product as an entry point into a much larger materials platform.
Slide 7: The Team
The team slide features the two co-founders, Alec Brewer (CEO) and Kobe Rogers (COO). Both have undergraduate degrees (B.S. BME and B.S. Chemistry, respectively) and five years of relevant experience. The right side of the slide is crowded with 18 logos of accelerators, universities, and organizations, including Plug and Play, MassChallenge, EPA, Virginia Tech, and Lighthouse Labs . This serves as significant social proof for a young team.
Slide 8: The Ask
The 'Ask' slide is surprisingly vague. It requests "Pre-seed/Seed Investor Intros," "Organic Waste Streams," and "Corporate Champion(s)." There is no mention of a specific funding goal, valuation, or use of proceeds. This is a missed opportunity to signal the scale of the company's immediate needs to potential investors.
Slide 9: Contact Slide
The deck concludes with a 'Thank You' slide providing the email addresses for both Alec Brewer and Kobe Rogers. It maintains the consistent branding seen throughout the presentation.
What Ourobio Does Well
Technical Clarity: The deck does an excellent job of explaining a complex biological process in simple terms. The use of flowcharts on slides 3 and 4 makes the circular economy aspect easy to grasp for non-scientists.
Social Proof: For a team that appears to be early in their careers, the sheer volume of accelerator and institutional logos on slide 7 provides a strong signal that the technology and the founders have been vetted by multiple reputable organizations.
Product Focus: Instead of claiming they will change every aspect of the chemical industry at once, they identify a very specific first product: blue masterbatches from dairy waste. This specificity makes the business feel more tangible and achievable.
What is Missing from the Ourobio Deck
Market Size: There is no mention of the Total Addressable Market (TAM). Investors need to know if the plastic colorant market is a $100 million opportunity or a $10 billion opportunity to justify the risks of biotech R&D.
Competition: The deck operates in a vacuum. There is no mention of other bioplastic companies or how Ourobio's process compares to existing methods of producing PHB or pigments. Without a competitive matrix, it is hard to judge the 'moat' of their proprietary bioprocess.
Financials and Unit Economics: There are no projections, no current burn rate, and no discussion of the cost-per-kilogram of their product versus traditional petrochemical colorants. In the chemicals industry, price parity is often the deciding factor for adoption.
The 'Hard' Ask: Asking for "intros" is passive. A fundraising deck should ideally state a specific amount (e.g., "Raising $1.5M") and explain what milestones that money will buy (e.g., "Scaling to TRL 6").
Founder Takeaways
Use TRLs to Communicate Progress: Ourobio’s use of Technology Readiness Levels (TRL) is a professional way to communicate R&D status to investors who understand deep tech. It provides a standardized language for progress that is more meaningful than just saying "we are in the lab."
Leverage Accelerator Logos: If you are a first-time founder, your 'pedigree' matters. Ourobio effectively uses the logos of organizations like the EPA and MassChallenge to build credibility that their resumes might not yet carry on their own.
Don't Forget the Business Case: While the science is compelling, a pitch deck is a business document. Founders should ensure that for every slide of science, there is a corresponding slide of business logic—market size, competitive advantage, and financial sustainability.
Frequently asked questions
- What is Ourobio's primary product?
- According to slide 4, Ourobio's first product is a 'blue biosynthetic masterbatch.' This is a low-footprint, biodegradable plastic colorant produced from dairy waste (whey) using a proprietary single-step fermentation process. The company intends to expand this into a broader portfolio of multi-colored masterbatches and PHA co-polymers as outlined in their roadmap on slide 6.
- What stage of development is the technology in?
- Slide 5 states that the company has reached Technology Readiness Level (TRL) 3/4. This indicates they have moved past basic research into the proof-of-concept and laboratory validation phase. They have successfully produced polymers and colorants from whey using their engineered strains and have secured a provisional patent as of March 2022.
- Who are the founders of Ourobio?
- The company was co-founded by Alec Brewer (CEO) and Kobe Rogers (COO). Alec Brewer holds a B.S. in Biomedical Engineering and has five years of entrepreneurship experience. Kobe Rogers holds a B.S. in Chemistry and has five years of experience in independent biochemistry R&D. Both are featured on slide 7.
- How much money is Ourobio raising?
- The deck does not state a specific dollar amount. Slide 8, titled 'Our Ask,' lists 'Pre-seed/Seed Investor Intros' as a requirement, along with organic waste streams and corporate champions. The absence of a specific 'Ask' figure suggests this deck may be used for general networking or very early-stage introductory conversations.
- What market traction does Ourobio have?
- Traction is highlighted on slide 5, noting 1,000+ hours of market discovery. This effort resulted in Memorandums of Understanding (MOUs) from both upstream (waste providers) and downstream (product buyers) partners. Additionally, they were recognized by StartUs Insights as one of the '5 Top Biomaterials Startups you should watch in 2022.'
